Skip to main content

Boston Scientific MedSurg revenue

  • BSX · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$44.34+0.32%Close 13 Nov 2026 · Market value $63.59B

MedSurg revenue at Boston Scientific came to $1.7B for the quarter to 30 Sep 2026, up 0.6% from a year earlier.

As Boston Scientific reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 2 Nov 2026.

By quarter

$1.4BDec 2023$1.4BMar 2024$1.5BJun 2024$1.5BSep 2024$1.6BDec 2024$1.6BMar 2025$1.7BJun 2025$1.7BSep 2025$1.8BDec 2025$1.7BMar 2026$1.8BJun 2026$1.7BSep 2026
Boston Scientific MedSurg revenue, every reported period
Period endingMedSurg revenueChange on a yearFiled
30 Sep 2026$1.7Bup 0.6%2 Nov 2026
30 Jun 2026$1.8Bup 5.9%3 Aug 2026
31 Mar 2026$1.7Bup 7.9%1 May 2026
31 Dec 2025$1.8Bup 11.7%17 Feb 2026
30 Sep 2025$1.7Bup 16.4%3 Nov 2025
30 Jun 2025$1.7Bup 15.7%1 Aug 2025
31 Mar 2025$1.6Bup 11.7%1 May 2025
31 Dec 2024$1.6Bup 12.4%18 Feb 2025
30 Sep 2024$1.5Bup 10.3%1 Nov 2024
30 Jun 2024$1.5Bup 9.0%1 Aug 2024
31 Mar 2024$1.4Bup 10.3%1 May 2024
31 Dec 2023$1.4Bup 11.1%20 Feb 2024
30 Sep 2023$1.3Bup 10.6%1 Nov 2023
30 Jun 2023$1.4Bup 9.0%3 Aug 2023
31 Mar 2023$1.3Bup 11.0%4 May 2023
31 Dec 2022$1.3Bup 4.3%23 Feb 2023
30 Sep 2022$1.2Bup 6.6%3 Nov 2022
30 Jun 2022$1.2Bup 4.4%4 Aug 2022
31 Mar 2022$1.2Bup 9.0%5 May 2022
31 Dec 2021$1.2Bup 39.5%23 Feb 2022
30 Sep 2021$1.1Bup 37.9%4 Nov 2021
30 Jun 2021$1.2Bup 107.5%6 Aug 2021
31 Mar 2021$1.1Bup 36.7%6 May 2021
31 Dec 2020$891.0Mup 1.5%23 Feb 2021
30 Sep 2020$825.0Mdown 2.4%5 Nov 2020
30 Jun 2020$576.0Mdown 29.6%5 Aug 2020
31 Mar 2020$774.0Mup 1.0%6 May 2020
31 Dec 2019$878.0Mup 9.7%25 Feb 2020
30 Sep 2019$845.0Mup 13.3%5 Nov 2019
30 Jun 2019$818.0Mup 8.9%30 Jul 2019
31 Mar 2019$766.0Mup 7.7%29 Apr 2019
31 Dec 2018$800.0M—19 Feb 2019
30 Sep 2018$746.0Mup 10.4%29 Oct 2018
30 Jun 2018$751.0Mup 10.4%31 Jul 2018
31 Mar 2018$711.0M—1 May 2018
30 Sep 2017$676.0M—2 Nov 2017
30 Jun 2017$680.0M—3 Aug 2017

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Boston Scientific: Interventional Cardiology & Vascular Therapies revenue · Electrophysiology revenue · Endoscopy revenue · Peripheral Interventions revenue · Urology revenue · Cardiac Rhythm Management revenue · Watchman revenue · Neuromodulation revenue · Interventional Oncology & Embolization revenue · Cardiology revenue · Cardiovascular revenue · United States revenue · Int'l revenue · Emerging Markets revenue · financial statements

Every KPI and segment of BSX, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.